Cornerstone Wealth Group, LLC Bristol Myers Squibb CO Transaction History
Cornerstone Wealth Group, LLC
- $1.21 Billion
- Q2 2024
A detailed history of Cornerstone Wealth Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Wealth Group, LLC holds 13,886 shares of BMY stock, worth $681,108. This represents 0.05% of its overall portfolio holdings.
Number of Shares
13,886
Previous 12,915
7.52%
Holding current value
$681,108
Previous $700,000
17.71%
% of portfolio
0.05%
Previous 0.06%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,475Shares Held
1.49BCall Options Held
26MPut Options Held
20M-
Vanguard Group Inc Valley Forge, PA186MShares$9.13 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY163MShares$7.97 Billion0.21% of portfolio
-
State Street Corp Boston, MA91.6MShares$4.49 Billion0.23% of portfolio
-
Jpmorgan Chase & CO New York, NY88.8MShares$4.36 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$3.44 Billion0.79% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...